Alerts will be sent to your verified email
Verify Email
RAMAVISION
|
Rama Vision
|
Biogen Pharmachem
|
Synoptics Techno.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.61 % | 0.21 % | 18.17 % |
|
5yr average Equity Multiplier
|
1.69 | 1.01 | 2.21 |
|
5yr Average Asset Turnover Ratio
|
1.86 | 0.02 | 0.83 |
|
5yr Avg Net Profit Margin
|
1.98 % | -19.83 % | 10.3 % |
|
Price to Book
|
2.69 | 0.89 | 0.0 |
|
P/E
|
30.75 | 67.71 | 20.56 |
|
5yr Avg Cash Conversion Cycle
|
69.81 Days | 0.0 | 143.38 Days |
|
Inventory Days
|
77.95 Days | 0.0 | 31.05 Days |
|
Days Receivable
|
19.66 Days | 0.0 | 156.48 Days |
|
Days Payable
|
6.81 Days | 1109.22 Days | 96.0 Days |
|
5yr Average Interest Coverage Ratio
|
4.22 | 902.8 | 3.98 |
|
5yr Avg ROCE
|
11.41 % | 0.21 % | 23.83 % |
|
5yr Avg Operating Profit Margin
|
4.78 % | -19.88 % | 27.05 % |
|
5 yr average Debt to Equity
|
0.43 | 0.0 | 0.75 |
|
5yr CAGR Net Profit
|
143.01 % | n/a | 24.12 % |
|
5yr Average Return on Assets
|
3.69 % | 0.21 % | 8.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.22 % | 0.0 | 73.11 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.84 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Rama Vision
|
Biogen Pharmachem
|
Synoptics Techno.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|